HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model
<strong>Background:</strong> Sustainable Development Goals set a challenge for the elimination of hepatitis B virus (HBV) infection as a public health concern by the year 2030. Deployment of a robust prophylactic vaccine and enhanced interventions for prevention of mother to child transm...
Main Authors: | McNaughton, A, Lourenco, J, Hattingh, L, Adland, E, Daniels, S, Van Zyl, A, Akiror, C, Wareing, S, Jeffery, K, Ansari, M, Klenerman, P, Goulder, P, Gupta, S, Jooste, P, Matthews, P |
---|---|
Format: | Journal article |
Published: |
BioMed Central
2019
|
Similar Items
-
HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model
by: Anna L. McNaughton, et al.
Published: (2019-02-01) -
Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa
by: Jooste, P, et al.
Published: (2016) -
PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort.
by: Sharp, C, et al.
Published: (2017) -
Hepatitis B virus (HBV) adaptation to the CD8+ T cell response: consequences for host and pathogen
by: Lumley, S, et al.
Published: (2018) -
PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort [version 1; referees: 2 approved]
by: Colin P. Sharp, et al.
Published: (2017-04-01)